Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |